Movement Disorders
Browse Articles, recent Forum and News posts, Patient Handouts, External Resources, and Featured Images and Videos concerned with movement disorders.
In the spotlight
Gait disordersHemifacial spasm
Imaging of movement disorders
Movement disorder emergencies
Movement disorders associated with autoimmune encephalitis
Movement disorders in childhood
Neuro-ophthalmology of movement disorders
Parkinson disease
Posttraumatic movement disorders
Rating scales of movement disorders
Stiff-person syndrome
Parkinsonism in Idiopathic Disorders
ALS-like disorders of the Western PacificCorticobasal degeneration
Dementia in Parkinson disease
Dementia with Lewy bodies
Idiopathic basal ganglia calcification
Multiple system atrophy
Progressive supranuclear palsy
Progressive supranuclear palsy: cognitive and behavioral changes
Tauopathies with dementia and parkinsonism
Wilson disease
Parkinsonism in Acquired Disorders
Acquired hepatocerebral degenerationNeuroleptic malignant syndrome
Nocturnal Movement Disorders
Benign sleep myoclonus of infancyParoxysmal dyskinesias
Periodic limb movements
Restless legs syndrome
Sleep and cerebral degenerative disorders
Sleep bruxism
Sleep-related leg cramps
Sleep-related movement disorders
Sleep-related rhythmic movement disorder
Ataxia & Tremor
Acquired hepatocerebral degenerationAtaxia
Fragile X-associated tremor/ataxia syndrome
Spinocerebellar ataxia type 3
Tremors
Wilson disease
Chorea & Tics
ChoreaChorea in childhood
Hemiballism
Huntington disease
Juvenile Huntington disease
Neuroacanthocytosis
Paroxysmal dyskinesias
Sydenham chorea
Tourette syndrome
Wilson disease
Drug-Induced Movements
Acute drug-induced movement disordersDrug-induced parkinsonism
Tardive dystonia
Other Hyperkinetic Disorders
AkathisiaBenign sleep myoclonus of infancy
Blepharospasm
Cervical dystonia
Dopa-responsive dystonia
Isolated dystonia
Limb dystonia
Myoclonus
Opsoclonus-myoclonus
Oromandibular dystonia
Peripheral dystonia
Spasmodic dysphonia
Stereotypies
Tardive dyskinesia
Treatment Information
Deep brain stimulation in movement disordersEntacapone
Levodopa
Neurodegenerative disorders: treatment with neurotrophic factors
Pramipexole
Rasagiline
Risperidone
Ropinirole
Rotigotine
Selegiline
Tolcapone
Related Topics
Basal ganglia: functional anatomy and neuropharmacologyCatatonia
Functional (psychogenic) movement disorders
Idiopathic basal ganglia calcification
Motor control of movement disorders
Movement disorders associated with infection
Sleep and parkinsonism
Sleep bruxism
Sleep-related movement disorders
Forum
Interact with your peers.
News
See what's being published in neurology and the neurosciences.
Jan 11, 2021
Study sheds light on reason levodopa declines in efficacy after a few years' use.
Effects of Huntington’s disease mutation may begin in childhood
Jan 07, 2021
The neurodevelopmental hypothesis of Huntington disease suggests its origins are rooted in childhood when the mutant gene that causes the disease begins to affect both brain and body growth and development.
COVID-19 infection may be part of a “perfect storm” for Parkinson disease
Oct 23, 2020
Can COVID-19 infection increase the risk of developing Parkinson disease?
View AllPatient Handouts
Print or email information for your patients when needed.
Dystonias
Estimulación cerebral profunda para la enfermedad de Parkinson
Mioclonos (Spanish)
Myoclonus
Restless legs syndrome
Sindrome de las piernas inquietas (Spanish)
Temblor (Spanish)
Tourette syndrome
Tremor
Guidelines
AAN: Botulinum Neurotoxin For the Treatment of Movement Disorders
AAN: Botulinum Neurotoxin For the Treatment of Spasticity
AAN: Diagnosis and prognosis of new onset Parkinson disease
AAN: Efficacy and safety of medical marijuana in selected neurologic disorders
AAN: Movement Disorders
AAN: Neuroprotective strategies and alternative therapies for Parkinson disease
AAN: Pharmacologic treatment of chorea in Huntington disease
AAN: Treatment of essential tremor
AAN: Treatment of nonmotor symptoms of Parkinson disease
AAN: Treatment of tardive syndromes
MDS Rating Scales
Recommendations for the predictive genetic test in Huntington disease
Quality Measures
AAN: Physician Performance Measurement Set
OtherExternal Resources
Explore other relevant websites. Close the window to return to MedLink.
Alerts and Advisories
FDA: Carbidopa/Levodopa and Entacapone: Ongoing Safety Review (2015)
Guidelines
UMSARS and other MSA rating scales
Testing
LRRK2-Related Parkinson Disease
Clinical Trials
NIH: Parkinsonian Disorders
Featured Images and Videos
Learn from examples.
